If at first you don't succeed: Stem-cell transplantation for acute myeloid leukemia after first relapse

Journal of Clinical Oncology

Volumn 31, Issue 10, 2013, Pages 1259-1261

  Schiffer, Charles A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CLINICAL PRACTICE; CYTOGENETICS; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EDITORIAL; GRAFT VERSUS LEUKEMIA EFFECT; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; INTENTION TO TREAT ANALYSIS; KARYOTYPE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKEMOGENESIS; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; REDUCED INTENSITY CONDITIONING; STEM CELL TRANSPLANTATION; TREATMENT FAILURE;

FEMALE; HUMANS; LEUKEMIA, MYELOID; MALE; STEM CELL TRANSPLANTATION;

EID: 84876089241     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.4241     Document Type: Editorial

References (16)

1. Wheatley K, Gray R: Commentary: Mendelian randomization - An update on its use to evaluate allogeneic stem cell transplantation in leukaemia. Int J Epidemiol 33:15-17, 2004 (Pubitemid 38500148)
2. Koreth J, Schlenk R, Kopecky KJ, et al: Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-analysis of prospective clinical trials. JAMA 301:2349-2361, 2009
3. Gooley TA, Chien JW, Pergam SA, et al: Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091-2101, 2010
4. Burnett AK, Goldstone A, Hills RK, et al: Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission. J Clin Oncol 31:1293-1301, 2013
5. Schiffer CA, Lee EJ: Approaches to the therapy of relapsed acute myeloid leukemia. Oncology (Williston Park) 3:23-27, 1989 (Pubitemid 19223690)
6. Schlenk RF, Döhner K, Krauter J, et al: Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1909-1918, 2008 (Pubitemid 351620111)
7. Marcucci G, Haferlach T, Döhner K, et al: Molecular genetics of adult acute myeloid leukemia: Prognostic and therapeutic implications. J Clin Oncol 29:475-486, 2011
8. Patel JP, Gönen M, Figueroa ME, et al: Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 366:1079-1089, 2012
9. Baldus CD, Thiede C, Soucek S, et al: BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: Prognostic implications. J Clin Oncol 24:790-797, 2006 (Pubitemid 46622046)
10. Gale RE, Hills R, Kottaridis PD, et al: No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): An analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials. Blood 106:3658-3665, 2005 (Pubitemid 41609208)
11. Brunet S, Labopin M, Esteve J, et al: Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: A retrospective analysis. J Clin Oncol 30:735-741, 2012
12. Fang M, Storer B, Estey E, et al: Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood 118:1490-1494, 2011
13. Schiffer CA: "Anything you can't do, I can't do either": Transplantation for high risk AML [podcast]. J Clin Oncol 30, 2012 http://jco.ascopubs.org/content/30/7/735/suppl/DC1
14. Walter RB, Gooley TA, Wood BL, et al: Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol 29:1190-1197, 2011
15. Fearon ER, Burke PJ, Schiffer CA, et al: Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med 315:15-24, 1986 (Pubitemid 16093246)
16. Norkin M, Uberti JP, Schiffer CA: Very late recurrences of leukemia: Why does leukemia awake after many years of dormancy? Leuk Res 35:139-144, 2011